查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
药物器械组合产品市场：按产品类型、应用、最终用户、地区 - 规模、份额、展望、机会分析，2022-2028 年
市场调查报告书
商品编码
1181744

药物器械组合产品市场：按产品类型、应用、最终用户、地区 - 规模、份额、展望、机会分析，2022-2028 年

Drug Device Combination Product Market, By Products Type, By Application, By End-User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 201 Pages | 商品交期: 2-3个工作天内

价格
简介目录

组合产品是将药物、医疗器械和生物製剂组合在一起以实现更安全、更有效治疗的治疗/诊断产品。 组合产品是将至少两种产品（一种医疗器械和一种药物）结合起来共同治疗的产品。 因此，对结合医疗器械和药品的产品的需求正在增加。

市场动态

慢性病负担加重、老年人口不断增加、确保患者安全的有利政府政策和举措、COVID-19（大流行）爆发以及市场参与者推出新产品是预计将推动全球增长的主要因素预测期内的药物器械组合产品市场。

例如，根据美国疾病控制与预防中心 (CDC) 的数据，美国每 10 人中就有 6 人至少患有一种慢性疾病，例如心脏病、中风、癌症或糖尿病。 这些和其他慢性病是美国死亡和残疾的主要原因，也是医疗保健费用的主要原因。

此外，2020 年 10 月，美敦力 (Medtronic) 的 Abre 静脉自扩张支架系统获得了美国食品药品监督管理局 (FDA) 的批准。 该系统适用于有症状的髂股流出道阻塞患者的髂股静脉。

这项研究的主要特点

  • 本报告对全球药物器械组合产品市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2028 年）的市场规模和復合年增长率 (CAGR%)。它提供。
  • 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
  • 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
  • 它根据以下参数（包括公司亮点、产品组合、主要亮点、财务业绩和战略）介绍了全球药械组合产品市场的主要参与者。
  • 本研究涵盖的主要公司包括 AbbVie Inc.（Allergan）、Terumo Corporation、GlaxoSmithKline PLC、Novartis AG、Medtronic PLC、Abbott Laboratories、Boston Scientific Corp.、W L Gore and Associates Inc.、Stryker Corporation 和Becton、Dickinson and Company 等。
  • 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
  • 本研究报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球药物器械组合产品市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况：按产品分类
    • 市场概况：按应用分类
    • 市场概况：按最终用户分类
    • 市场概况：按地区
  • 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

  • 市场动态
    • 慢性病负担增加
    • 产品召回和相关并发症
    • COVID-19（全球大流行）爆发
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/批准
  • 害虫分析
  • 对 PORTER 的分析
  • 合併/收购场景

第 4 章全球药物器械组合产品市场 - 冠状病毒 (COVID-19) 大流行的影响

  • COVID-19 的流行病学特征
  • 供应方和需求方分析
  • 经济影响

第 5 章全球药物器械组合产品市场，按产品分类，2017-2028

  • 药物洗脱支架
  • 透皮贴剂
  • 输液泵
  • 药物洗脱球囊
  • 吸入器
  • 其他产品

第 6 章：2017-2028 年按应用分列的药械组合产品全球市场

  • 心血管
  • 糖尿病治疗
  • 癌症治疗
  • 呼吸系统疾病
  • 其他应用领域

第 7 章全球药物-器械组合市场，按最终用户，2017-2028

  • 医院
  • 门诊手术中心
  • 其他最终用户

第 8 章：2017-2028 年按地区分列的全球药械组合产品市场

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
  • 世界其他地区

第9章竞争格局

  • AbbVie Inc.（Allergan）
  • Terumo Corporation
  • GlaxoSmithKline PLC
  • Novartis AG
  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corp.
  • W L Gore and Associates Inc.
  • Stryker Corporation
  • Becton, Dickinson and Company

第 10 章

  • 调查方法介绍
  • 关于出版商
简介目录
Product Code: CMI3919

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments. Combination products include at least two products, one, of medical device and other of drugs that work in coordination to treat. Thus, there is an increase in demand for drug device combination products.

Market Dynamics:

Rise in burden of chronic disorders, growing geriatric population, favorable government policies or initiatives to ensure patient safety, the outbreak of COVID-19 (pandemic), and the introduction of novel products by market players are major factors expected to drive growth of the global drug device combination product market over the forecast period.

For instance, according to the Centers for Disease Control and Prevention (CDC), 6 in 10 people in the United States live with at least one chronic disease, such as heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in the U.S., and they are also a leading driver of health care costs.

Moreover, in October 2020, Medtronic received the U.S. Food and Drug Administration (FDA) approval for the Abre Venous Self-Expanding Stent System. The system is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction.

Key features of the study:

  • This report provides in-depth analysis of the global drug device combination product market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global drug device combination product market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include AbbVie Inc. (Allergan), Terumo Corporation, GlaxoSmithKline PLC, Novartis AG, Medtronic PLC, Abbott Laboratories, Boston Scientific Corp., W L Gore and Associates Inc., Stryker Corporation, and Becton, Dickinson and Company, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global drug device combination product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug device combination product market.

Detailed Segmentation:

  • Global Drug Device Combination Product Market, By Products:
    • Drug Eluting Stents
    • Transdermal Patches
    • Infusion Pumps
    • Drug Eluting Balloon
    • Inhalers
    • Other Products
  • Global Drug Device Combination Product Market, By Application:
    • Cardiovascular
    • Diabetes
    • Cancer Treatment
    • Respiratory Diseases
    • Other Applications
  • Global Drug Device Combination Product Market, By End-Users:
    • Hospitals
    • Ambulatory Surgical Centers
    • Other End-Users
  • Global Drug Device Combination Product Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • AbbVie Inc. (Allergan)
    • Terumo Corporation
    • GlaxoSmithKline PLC
    • Novartis AG
    • Medtronic PLC
    • Abbott Laboratories
    • Boston Scientific Corp.
    • W L Gore and Associates Inc.
    • Stryker Corporation
    • Becton, Dickinson and Company

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Products
    • Market Snapshot, By Application
    • Market Snapshot, By End-Users
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in burden of chronic disorders
    • Product recalls and associated complications
    • Outbreak of COVID-19 (global pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Drug Device Combination Product Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Drug Device Combination Product Market, By Products, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Drug Eluting Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Transdermal Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Infusion Pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Drug Eluting Balloon
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Drug Device Combination Product Market, By Application, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Cancer Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Respiratory Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Drug Device Combination Product Market, By End Users, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other End Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Global Drug Device Combination Product Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

9. Competitive Landscape

  • AbbVie Inc. (Allergan)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corp.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • W L Gore and Associates Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us